MicroRNAs: Novel players in the dialogue between pancreatic islets and immune system in autoimmune diabetes

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Ventriglia, Giuliana ^a,b   Nigi, Laura ^a,b   Sebastiani, Guido ^a,b   Dotta, Francesco ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b Fondazione Umberto di Mario ONLUS C/o Toscana Life Science Park ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; INSULIN;

AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELLS; DIABETES MELLITUS; ENDOCRINE CELL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; REVIEW; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICRORNAS;

EID: 84939539006     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/749734     Document Type: Review

References (87)

1. D. L. Eizirik, M. L. Colli, and F. Ortis, "Therole of inflammation in insulitis and β-cell loss in type 1 diabetes," Nature Reviews Endocrinology, vol. 5, no. 4, pp. 219-226, 2009.
2. E. Roggli, A. Britan, S. Gattesco et al. , "Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells," Diabetes, vol. 59, no. 4, pp. 978-986, 2010.
3. F. Salas-Pérez, E. Codner, E. Valencia, C. Pizarro, E. Carrasco, and F. Pérez-Bravo, "MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes," Immunobiology, vol. 218, no. 5, pp. 733-737, 2013.
4. G. Sebastiani, F. A. Grieco, I. Spagnuolo, L. Galleri, D. Cataldo, and F. Dotta, "Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity," Diabetes/Metabolism Research and Reviews, vol. 27, no. 8, pp. 862-866, 2011.
5. The microRNA database, miRbase release no. 21, 2014, http://www.mirbase.org/.
6. C. Guay, E. Roggli, V. Nesca, C. Jacovetti, and R. Regazzi, "Diabetes mellitus, a microRNA-related disease?"Translational Research, vol. 157, no. 4, pp. 253-264, 2011.
7. B. S. Cobb, T. B. Nesterova, E. Thompson et al. , "T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer," The Journal of Experimental Medicine, vol. 201, no. 9, pp. 1367-1373, 2005.
8. S. A. Muljo, K. MarkAnsel, C. Kanellopoulou, D. M. Livingston, A. Rao, and K. Rajewsky, "Aberrant T cell differentiation in the absence of Dicer," The Journal of Experimental Medicine, vol. 202, no. 2, pp. 261-269, 2005.
9. M. M. W. Chong, J. P. Rasmussen, A. Y. Rudensky, and D. R. Littman, "The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease," The Journal of Experimental Medicine, vol. 205, no. 9, pp. 2005-2017, 2008.
10. D. F. Steiner, M. F. Thomas, J. K. Hu et al. , "MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells," Immunity, vol. 35, no. 2, pp. 169-181, 2011.
11. S. B. Koralov, S. A. Muljo, G. R. Galler et al. , "Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage," Cell, vol. 132, no. 5, pp. 860-874, 2008.
12. S. Xu, K. Guo, Q. Zeng, J. Huo, and K.-P. Lam, "The RNase III enzyme Dicer is essential for germinal center B-cell formation," Blood, vol. 119, no. 3, pp. 767-776, 2012.
13. E. Gambineri, T. R. Torgerson, and H. D. Ochs, "Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis," Current Opinion in Rheumatology, vol. 15, no. 4, pp. 430-435, 2003.
14. X. Zhou, L. T. Jeker, B. T. Fife et al. , "Selective miRNAdisruption in T reg cells leads to uncontrolled autoimmunity," Journal of Experimental Medicine, vol. 205, no. 9, pp. 1983-1991, 2008.
15. L. T. Jeker, X. Zhou, R. Blelloch, and J. A. Bluestone, "DGCR8-mediated production of canonical microRNAs is critical for regulatory T cell function and stability," PLoS ONE, vol. 8, no. 5, Article ID e66282, 2013.
16. A. Liston, L.-F. Lu, D. OCarroll, A. Tarakhovsky, and A. Y. Rudensky, "Dicer-dependent microRNA pathway safeguards regulatory T cell function," Journal of Experimental Medicine, vol. 205, no. 9, pp. 1993-2004, 2008.
17. B. S. Cobb, A. Hertweck, J. Smith et al. , "A role for Dicer in immune regulation," Journal of ExperimentalMedicine, vol. 203, no. 11, pp. 2519-2527, 2006.
18. A. Marson, K. Kretschmer, G. M. Frampton et al. , "Foxp3 occupancy and regulation of key target genes during T-cell stimulation," Nature, vol. 445, no. 7130, pp. 931-935, 2007.
19. L.-F. Lu, T.-H. Thai, D. P. Calado et al. , "Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein," Immunity, vol. 30, no. 1, pp. 80-91, 2009.
20. S. Kohlhaas, O. A. Garden, C. Scudamore, M. Turner, K. Okkenhaug, and E. Vigorito, "Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells1," Journal of Immunology, vol. 182, no. 5, pp. 2578-2582, 2009.
21. L.-F. Lu, M. P. Boldin, A. Chaudhry et al. , "Function of miR-146a in controlling Treg cell mediated regulation of Th1 responses," Cell, vol. 142, no. 6, pp. 914-929, 2010.
22. L. T. Jeker, X. Zhou, K. Gershberg et al. , "MicroRNA 10a marks regulatory T cells," PLoS ONE, vol. 7, no. 5, Article ID e36684, 2012.
23. H. Takahashi, T. Kanno, S. Nakayamada et al. , "TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells," Nature Immunology, vol. 13, no. 6, pp. 587-595, 2012.
24. G. J. Berry, L. R. Budgeon, T. K. Cooper, N. D. Christensen, and H. Waldner, "The type 1 diabetes resistance locus B10 Idd9. 3 mediates impaired B-cell lymphopoiesis and implicates microRNA-34a in diabetes protection," European Journal of Immunology, vol. 44, no. 6, pp. 1716-1727, 2014.
25. R. Hezova, O. Slaby, P. Faltejskova et al. , "microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients," Cellular Immunology, vol. 260, no. 2, pp. 70-74, 2010.
26. M. L. Yang, L. Ye, B. Wang et al. , "Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients," Journal of Diabetes, vol. 7, no. 2, pp. 158-165, 2015.
27. C. Du, C. Liu, J. Kang et al. , "MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis," Nature Immunology, vol. 10, no. 12, pp. 1252-1259, 2009.
28. J. Diana, L. Gahzarian, Y. Simoni, and A. Lehuen, "Innate immunity in type 1 diabetes," DiscoveryMedicine, vol. 11, no. 61, pp. 513-520, 2011.
29. J. Diana, Y. Simoni, L. Furio et al. , "Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes," Nature Medicine, vol. 19, no. 1, pp. 65-73, 2013.
30. F. A. Grieco, F. Vendrame, I. Spagnuolo, and F. Dotta, "Innate immunity and the pathogenesis of type 1 diabetes," Seminars in Immunopathology, vol. 33, no. 1, pp. 57-66, 2011.
31. B. Poligone, D. J. Weaver Jr. , P. Sen, A. S. Baldwin, and R. Tisch, "Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function," The Journal of Immunology, vol. 168, no. 1, pp. 188-196, 2002.
32. R. J. Steptoe, J. M. Ritchie, and L. C. Harrison, "Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice," The Journal of Immunology, vol. 168, no. 10, pp. 5032-5041, 2002.
33. A. Valle, G. M. Giamporcaro, M. Scavini et al. , "Reduction of circulating neutrophils precedes and accompanies type 1 diabetes," Diabetes, vol. 62, no. 6, pp. 2072-2077, 2013.
34. J. G. M. Markle, S. Mortin-Toth, A. S. L. Wong, L. Geng, A. Hayday, and J. S. Danska, "γδ T cells are essential effectors of type 1 diabetes in the nonobese diabetic mouse model," Journal of Immunology, vol. 190, no. 11, pp. 5392-5401, 2013.
35. E. Lien and D. Zipris, "The role of toll-like receptor pathways in the mechanism of type 1 diabetes," CurrentMolecularMedicine, vol. 9, no. 1, pp. 52-68, 2009.
36. S. Devaraj, M. R. Dasu, J. Rockwood, W. Winter, S. C. Griffen, and I. Jialal, "Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state," Journal of Clinical Endocrinology andMetabolism, vol. 93, no. 2, pp. 578-583, 2008.
37. M. F. Alemdehy, N. G. J. A. van Boxtel, H. W. J. de Looper et al. , "Dicer1 deletion in myeloid-committed progenitors causes neutrophil dysplasia and blocks macrophage/dendritic cell development in mice," Blood, vol. 119, no. 20, pp. 4723-4730, 2012.
38. H. Kuipers, F. M. Schnorfeil, H.-J. Fehling, H. Bartels, and T. Brocker, "Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo," Journal of Immunology, vol. 185, no. 1, pp. 400-409, 2010.
39. X. He, Z. Jing, and G. Cheng, "MicroRNAs: new regulators of toll-like receptor signalling pathways," BioMed Research International, vol. 2014, Article ID 945169, 14 pages, 2014.
40. M. Y. Donath, J. Størling, L. A. Berchtold, N. Billestrup, and T. Mandrup-Poulsen, "Cytokines and β-cell biology: fromconcept to clinical translation," Endocrine Reviews, vol. 29, no. 3, pp. 334-350, 2008.
41. X. Ma, L. E. Becker Buscaglia, J. R. Barker, and Y. Li, "MicroRNAs in NF-κB signaling," Journal of Molecular Cell Biology, vol. 3, no. 3, pp. 159-166, 2011.
42. Q. Ruan, T. Wang, V. Kameswaran et al. , "The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic β cell death," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 29, pp. 12030-12035, 2011.
43. E. Roggli, S. Gattesco, D. Caille et al. , "Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice," Diabetes, vol. 61, no. 7, pp. 1742-1751, 2012.
44. V. Bravo-Egana, S. Rosero, D. Klein et al. , "Inflammationmediated regulation of microRNA expression in transplanted pancreatic islets," Journal of Transplantation, vol. 2012, Article ID 723614, 15 pages, 2012.
45. F. Ortis, N. Naamane, D. Flamez et al. , "Cytokines interleukin-1β and tumor necrosis factor-α regulate different transcriptional and alternative splicing networks in primary β-cells," Diabetes, vol. 59, no. 2, pp. 358-374, 2010.
46. Q.-S. Mi, H.-Z. He, Z. Dong, C. Isales, and L. Zhou, "MicroRNA deficiency in pancreatic islet cells exacerbates streptozotocininducedmurine autoimmune diabetes," Cell Cycle, vol. 9, no. 15, pp. 3127-3129, 2010.
47. K. Nielsen, M. Kruhøffer, T. rntoft et al. , "Gene expression profiles during beta cell maturation and after IL-1β exposure reveal important roles of Pdx-1 andNkx6. 1 for IL-1β sensitivity," Diabetologia, vol. 47, no. 12, pp. 2185-2199, 2004.
48. C. H. Bang-Berthelsen, L. Pedersen, T. Fløyel, P. H. Hagedorn, T. Gylvin, and F. Pociot, "Independent component and pathwaybased analysis of miRNA-regulated gene expression in a model of type 1 diabetes," BMC Genomics, vol. 12, article 97, 2011.
49. C. Talchai, S. Xuan, H. V. Lin, L. Sussel, and D. Accili, "Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure," Cell, vol. 150, no. 6, pp. 1223-1234, 2012.
50. H. Kaspi, R. Pasvolsky, and E. Hornstein, "Could microRNAs contribute to the maintenance of β cell identity?"Trends in Endocrinology andMetabolism, vol. 25, no. 6, pp. 285-292, 2014.
51. J. A. Weber, D. H. Baxter, S. Zhang et al. , "The microRNA spectrum in 12 body fluids," Clinical Chemistry, vol. 56, no. 11, pp. 1733-1741, 2010.
52. N. Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya, "Secretory mechanisms and intercellular transfer of microRNAs in living cells," Journal of Biological Chemistry, vol. 285, no. 23, pp. 17442-17452, 2010.
53. A. Turchinovich, L. Weiz, A. Langheinz, and B. Burwinkel, "Characterization of extracellular circulating microRNA," Nucleic Acids Research, vol. 39, no. 16, pp. 7223-7233, 2011.
54. D. J. Gibbings, C. Ciaudo, M. Erhardt, and O. Voinnet, "Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity," Nature Cell Biology, vol. 11, no. 9, pp. 1143-1149, 2009.
55. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells," Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
56. K. C. Vickers, B. T. Palmisano, B. M. Shoucri, R. D. Shamburek, and A. T. Remaley, "MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins," Nature Cell Biology, vol. 13, no. 4, pp. 423-435, 2011.
57. J. D. Arroyo, J. R. Chevillet, E. M. Kroh et al. , "Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 5003-5008, 2011.
58. A. Turchinovich, L. Weiz, and B. Burwinkel, "Extracellular miRNAs: the mystery of their origin and function," Trends in Biochemical Sciences, vol. 37, no. 11, pp. 460-465, 2012.
59. R. Ma, T. Jiang, and X. Kang, "CirculatingmicroRNAs incancer: origin, function and application," Journal of Experimental and Clinical Cancer Research, vol. 31, no. 1, article 38, 2012.
60. N. Kosaka, H. Iguchi, and T. Ochiya, "Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis," Cancer Science, vol. 101, no. 10, pp. 2087-2092, 2010.
61. C. Théry, L. Zitvogel, and S. Amigorena, "Exosomes: composition, biogenesis and function,"Nature Reviews Immunology, vol. 2, no. 8, pp. 569-579, 2002.
62. G. Hu, K. M. Drescher, and X. M. Chen, "Exosomal miRNAs: biological properties and therapeutic potential," Frontiers in Genetics, vol. 20, no. 3, article 56, 2012.
63. G. Lachenal, K. Pernet-Gallay, M. Chivet et al. , "Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity," Molecular and Cellular Neuroscience, vol. 46, no. 2, pp. 409-418, 2011.
64. J. Skog, T. Würdinger, S. van Rijn et al. , "Glioblastoma microvesicles transport RNAand proteins that promote tumour growth and provide diagnostic biomarkers," Nature Cell Biology, vol. 10, no. 12, pp. 1470-1476, 2008.
65. C. Harding, J. Heuser, and P. Stahl, "Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. ," Journal of Cell Biology, vol. 97, no. 2, pp. 329-339, 1983.
66. S. Ramachandran and V. Palanisamy, "Horizontal transfer of RNAs: exosomes as mediators of intercellular communication," Wiley Interdisciplinary Reviews: RNA, vol. 3, no. 2, pp. 286-293, 2012.
67. B. György, T. G. Szabo, M. Pasztoi et al. , "Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles," Cellular and Molecular Life Sciences, vol. 68, no. 16, pp. 2667-2688, 2011.
68. S. K. Ajit, "Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules," Sensors, vol. 12, no. 3, pp. 3359-3369, 2012.
69. J. C. Brase, D. Wuttig, R. Kuner, and H. Sültmann, "Serum microRNAs as non-invasive biomarkers for cancer," Molecular Cancer, vol. 26, no. 9, article 306, 2010.
70. C. Guay and R. Regazzi, "Circulating microRNAs as novel biomarkers for diabetes mellitus," Nature Reviews Endocrinology, vol. 9, no. 9, pp. 513-521, 2013.
71. R. A. Boon and K. C. Vickers, "Intercellular transport of microRNAs," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 2, pp. 186-192, 2013.
72. K. Wang, S. Zhang, J. Weber, D. Baxter, and D. J. Galas, "Export of microRNAs and microRNA-protective protein by mammalian cells," Nucleic Acids Research, vol. 38, no. 20, pp. 7248-7259, 2010.
73. M. Mittelbrunn, C. Gutiérrez-Vazquez, C. Villarroya-Beltri et al. , "Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells," Nature Communications, vol. 2, no. 1, article 282, 2011.
74. Y. Zhang, D. Liu, X. Chen et al. , "Secreted monocytic miR-150 enhances targeted endothelial cell migration," Molecular Cell, vol. 39, no. 1, pp. 133-144, 2010.
75. J. C. Brase, M. Johannes, T. Schlomm et al. , "Circulating miRNAs are correlated with tumor progression in prostate cancer," International Journal of Cancer, vol. 128, no. 3, pp. 608-616, 2011.
76. E. K. O. Ng, W. W. S. Chong, H. Jinet al. , "Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening," Gut, vol. 58, no. 10, pp. 1375-1381, 2009.
77. C. Guay, V. Menoud, S. Rome, and R. Regazzi, "Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells," Cell Communication and Signaling, vol. 13, no. 1, article 17, 2015.
78. F. Figliolini, V. Cantaluppi, M. de Lena et al. , "Isolation, characterization and potential role in beta cell-endothelium cross-talk of extracellular vesicles released from human pancreatic islets," PLoS ONE, vol. 9, no. 7, Article ID e102521, 2014.
79. G. Sebastiani, I. Spagnuolo, A. Patti et al. , "MicroRNA expression fingerprint in serumof type 1 diabetic patients," Diabetologia, vol. 55, p. S48, 2012.
80. L. B. Nielsen, C. Wang, K. Sørensen et al. , "Circulating levels of MicroRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression," Experimental Diabetes Research, vol. 2012, Article ID 896362, 7 pages, 2012.
81. R. M. OConnell, D. S. Rao, A. A. Chaudhuri, and D. Baltimore, "Physiological and pathological roles for microRNAs in the immune system," Nature Reviews Immunology, vol. 10, no. 2, pp. 111-122, 2010.
82. C. Gutiérrez-Vazquez, C. Villarroya-Beltri, M. Mittelbrunn, and F. ͆anchez-Madrid, "Transfer of extracellular vesicles during immune cell-cell interactions," Immunological Reviews, vol. 251, no. 1, pp. 125-142, 2013.
83. C. Théry, M. Ostrowski, and E. Segura, "Membrane vesicles as conveyors of immune responses," Nature Reviews Immunology, vol. 9, no. 8, pp. 581-593, 2009.
84. A. Bobrie, M. Colombo, G. Raposo, and C. Théry, "Exosome secretion: molecular mechanisms and roles in immune responses," Traffic, vol. 12, no. 12, pp. 1659-1668, 2011.
85. G. Raposo, H. W. Nijman, W. Stoorvogel et al. , "B lymphocytes secrete antigen-presenting vesicles,"The Journal of Experimental Medicine, vol. 183, no. 3, pp. 1161-1172, 1996.
86. L. Zitvogel, A. Regnault, A. Lozier et al. , "Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes," Nature Medicine, vol. 4, no. 5, pp. 594-600, 1998.
87. A. Salama, N. Fichou, M. Allard et al. , "MicroRNA-29b modulates innate and antigen-specific immune responses in mouse models of autoimmunity," PLoS ONE, vol. 9, no. 9, Article ID e106153, 2014.